Evidence map›Paper›PMID 42053308›Full record

ArticlemBio2026

Vancomycin disrupts mitochondrial morphology and function and impairs macrophage fungal killing.

Ebrima Bojang, Lozan Sheriff, Emma Morris, Sophie Rouvray, Man Shun Fu, Chloe Wellings, Ketema Abdissa, Victoria Stavrou, Callum Clark, Andrew D Southam and 7 more

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ebrima BojangInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Lozan SheriffInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Emma MorrisInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Sophie RouvrayInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Man Shun FuInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Chloe WellingsInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Ketema AbdissaResearch Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.ORCID 0009-0008-4916-8011
Victoria StavrouInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Callum ClarkInstitute of Microbiology & Infection, University of Birmingham, Birmingham, United Kingdom.
Andrew D SouthamPhenome Centre Birmingham and School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Warwick B DunnPhenome Centre Birmingham and School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
David BendingInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Jose R HombrebuenoInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
Ilse JacobsenResearch Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.
Sarah DimeloeInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Rebecca A HallKent Fungal Group, University of Kent, Canterbury, Kent, United Kingdom.ORCID 0000-0002-4908-8168
Rebecca A DrummondInstitute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-5424-7074

Funding

Biotechnology and Biological Sciences Research Council BB/T00746X/1Wellcome Trust 222389/Z/21/Z, 306743/Z/23/Z
6 · The paper itself

Abstract

Vancomycin is a widely prescribed antibiotic used in the treatment of gram-positive bacterial infections. We previously showed that this antibiotic disrupted protective antifungal immune responses via microbiome dysbiosis, enhancing susceptibility to invasive candidiasis. Antibiotics are an independent risk factor for developing this life-threatening fungal infection, but whether microbiota-independent mechanisms also drive this association is not clear. Here, we show that vancomycin directly impairs macrophage responses to

Indexed as

Anti-Bacterial AgentsAntifungal AgentsCandida albicansMacrophagesMitochondriaVancomycinAnimalsHumansMicePhagocytosisReactive Oxygen SpeciesAnti-Bacterial AgentsAntifungal AgentsReactive Oxygen SpeciesVancomycinCandida albicansfungihospital infectionsmacrophagesmitochondriapostantibiotic effectvancomycin

Identifiers

PMID42053308
PMCPMC13251413

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.